BioCryst Pharmaceuticals Inc. (BCRX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
04-Mar-24 5:25 PM
View: 
Milano Vincent
Director
BioCryst Pharmaceuticals Inc. (BCRX) 29-Feb-24Grant 999$5.63$5,624.372%
51.0K to 52.0K
04-Mar-24 4:32 PM
View: 
Heggie Theresa
Director
BioCryst Pharmaceuticals Inc. (BCRX) 29-Feb-24Grant 999$5.63$5,624.372%
50.86K to 51.86K
04-Jan-24 4:31 PM
View: 
Stonehouse Jon P
President & CEO
Director
BioCryst Pharmaceuticals Inc. (BCRX) 03-Jan-24Gift 20,000----(2%)
1.15M to 1.13M
04-Jan-24 4:31 PM
View: 
Stonehouse Jon P
President & CEO
Director
BioCryst Pharmaceuticals Inc. (BCRX) 03-Jan-24Gift 20,000----2%
1.13M to 1.15M
20-Dec-23 4:42 PM
View: 
Thackray Helen M.
Chief R&D Officer
BioCryst Pharmaceuticals Inc. (BCRX) 19-Dec-23Payment of Exercise 5,580$6.05$33,759.00(2%)
255.24K to 249.66K
20-Dec-23 4:38 PM
View: 
Gayer Charles K
Chief Commercial Officer
BioCryst Pharmaceuticals Inc. (BCRX) 19-Dec-23Payment of Exercise 2,482$6.05$15,016.10(< 1%)
277.01K to 274.53K
20-Dec-23 4:35 PM
View: 
Doyle Anthony
Chief Financial Officer
BioCryst Pharmaceuticals Inc. (BCRX) 19-Dec-23Payment of Exercise 2,482$6.05$15,016.10(1%)
229.93K to 227.44K
20-Dec-23 4:40 PM
View: 
Stonehouse Jon P
President & CEO
Director
BioCryst Pharmaceuticals Inc. (BCRX) 19-Dec-23Payment of Exercise 14,089$6.05$85,238.50(1%)
1.15M to 1.13M
20-Dec-23 4:33 PM
View: 
Barnes Alane P
Chief Legal Officer
BioCryst Pharmaceuticals Inc. (BCRX) 19-Dec-23Payment of Exercise 2,482$6.05$15,016.10(< 1%)
296.02K to 293.54K
18-Dec-23 4:40 PM
View: 
Gayer Charles K
Chief Commercial Officer
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Payment of Exercise 5,840$6.43$37,551.20(2%)
282.86K to 277.01K
18-Dec-23 4:37 PM
View: 
Doyle Anthony
Chief Financial Officer
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Payment of Exercise 5,475$6.43$35,204.20(2%)
235.4K to 229.93K
18-Dec-23 4:43 PM
View: 
Stonehouse Jon P
President & CEO
Director
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Payment of Exercise 13,592$6.43$87,396.60(1%)
1.16M to 1.15M
18-Dec-23 4:34 PM
View: 
Barnes Alane P
Chief Legal Officer
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Grant 64,000----27%
236.04K to 300.04K
18-Dec-23 4:34 PM
View: 
Barnes Alane P
Chief Legal Officer
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Payment of Exercise 4,015$6.43$25,816.40(1%)
300.04K to 296.02K
18-Dec-23 4:47 PM
View: 
Thackray Helen M.
Chief R&D Officer
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Grant 51,000----25%
207.28K to 258.27K
18-Dec-23 4:40 PM
View: 
Gayer Charles K
Chief Commercial Officer
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Grant 34,000----14%
248.85K to 282.86K
18-Dec-23 4:37 PM
View: 
Doyle Anthony
Chief Financial Officer
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Grant 34,000----17%
201.4K to 235.4K
18-Dec-23 4:43 PM
View: 
Stonehouse Jon P
President & CEO
Director
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Grant 127,500----12%
1.03M to 1.16M
18-Dec-23 4:47 PM
View: 
Thackray Helen M.
Chief R&D Officer
BioCryst Pharmaceuticals Inc. (BCRX) 14-Dec-23Payment of Exercise 3,031$6.43$19,489.30(1%)
258.27K to 255.24K
01-Dec-23 4:40 PM
View: 
Heggie Theresa
Director
BioCryst Pharmaceuticals Inc. (BCRX) 30-Nov-23Grant 956$5.88$5,621.282%
49.91K to 50.86K
01-Dec-23 4:42 PM
View: 
Milano Vincent
Director
BioCryst Pharmaceuticals Inc. (BCRX) 30-Nov-23Grant 956$5.88$5,621.282%
50.04K to 51.0K
05-Sep-23 4:43 PM
View: 
Milano Vincent
Director
BioCryst Pharmaceuticals Inc. (BCRX) 31-Aug-23Grant 791$7.11$5,624.012%
49.25K to 50.04K
05-Sep-23 4:41 PM
View: 
Heggie Theresa
Director
BioCryst Pharmaceuticals Inc. (BCRX) 31-Aug-23Grant 791$7.11$5,624.012%
49.11K to 49.91K
15-Jun-23 4:37 PM
View: 
Sanders MacHelle
Director
BioCryst Pharmaceuticals Inc. (BCRX) 15-Jun-23Sale 4,000$7.98$31,920.00(14%)
29.61K to 25.61K
15-Jun-23 4:33 PM
View: 
Hutson Nancy J
Director
BioCryst Pharmaceuticals Inc. (BCRX) 14-Jun-23Sale 12,866$8.04$103,443.00(14%)
94.68K to 81.82K
15-Jun-23 4:37 PM
View: 
Sanders MacHelle
Director
BioCryst Pharmaceuticals Inc. (BCRX) 13-Jun-23Grant 16,745----130%
12.87K to 29.61K
15-Jun-23 4:35 PM
View: 
Milano Vincent
Director
BioCryst Pharmaceuticals Inc. (BCRX) 13-Jun-23Grant 16,745----52%
32.51K to 49.25K
15-Jun-23 4:50 PM
View: 
Stonehouse Jon P
President & CEO
Director
BioCryst Pharmaceuticals Inc. (BCRX) 13-Jun-23Gift 25,000----(2%)
1.06M to 1.03M
15-Jun-23 4:42 PM
View: 
Lee Kenneth B Jr
Director
BioCryst Pharmaceuticals Inc. (BCRX) 13-Jun-23Grant 16,745----32%
52.12K to 68.86K
15-Jun-23 4:39 PM
View: 
Aselage Steve
Director
BioCryst Pharmaceuticals Inc. (BCRX) 13-Jun-23Grant 16,745----36%
46.59K to 63.34K
15-Jun-23 4:33 PM
View: 
Hutson Nancy J
Director
BioCryst Pharmaceuticals Inc. (BCRX) 13-Jun-23Grant 16,745----21%
77.94K to 94.68K
15-Jun-23 4:29 PM
View: 
Heggie Theresa
Director
BioCryst Pharmaceuticals Inc. (BCRX) 13-Jun-23Grant 16,745----52%
32.37K to 49.11K
15-Jun-23 4:31 PM
View: 
McKee Amy E
Director
BioCryst Pharmaceuticals Inc. (BCRX) 13-Jun-23Grant 16,745----130%
12.87K to 29.61K
15-Jun-23 4:28 PM
View: 
Abercrombie George B
Director
BioCryst Pharmaceuticals Inc. (BCRX) 13-Jun-23Grant 16,745----130%
12.87K to 29.61K
15-Jun-23 4:43 PM
View: 
Levin Alan G
Director
BioCryst Pharmaceuticals Inc. (BCRX) 13-Jun-23Grant 16,745----82%
20.34K to 37.09K
15-Jun-23 4:40 PM
View: 
Galson Steven K
Director
BioCryst Pharmaceuticals Inc. (BCRX) 13-Jun-23Grant 16,745----130%
12.87K to 29.61K
02-Jun-23 4:32 PM
View: 
Heggie Theresa
Director
BioCryst Pharmaceuticals Inc. (BCRX) 31-May-23Grant 680$8.27$5,623.602%
31.69K to 32.37K
02-Jun-23 4:34 PM
View: 
Levin Alan G
Director
BioCryst Pharmaceuticals Inc. (BCRX) 31-May-23Grant 1,360$8.27$11,247.207%
18.98K to 20.34K
02-Jun-23 4:36 PM
View: 
Milano Vincent
Director
BioCryst Pharmaceuticals Inc. (BCRX) 31-May-23Grant 680$8.27$5,623.602%
31.83K to 32.51K
05-Apr-23 4:33 PM
View: 
Thackray Helen M.
Chief R&D Officer
BioCryst Pharmaceuticals Inc. (BCRX) 03-Apr-23Sale (Planned) 7,000$8.29$58,030.00(3%)
214.28K to 207.28K
23-Mar-23 4:40 PM
View: 
Stonehouse Jon P
President & CEO
Director
BioCryst Pharmaceuticals Inc. (BCRX) 21-Mar-23Option Exercise 31,055$3.22$99,997.103%
1.03M to 1.06M
02-Mar-23 4:37 PM
View: 
Levin Alan G
Director
BioCryst Pharmaceuticals Inc. (BCRX) 28-Feb-23Grant 1,271$8.85$11,248.407%
17.71K to 18.98K
02-Mar-23 4:44 PM
View: 
Milano Vincent
Director
BioCryst Pharmaceuticals Inc. (BCRX) 28-Feb-23Grant 635$8.85$5,619.752%
31.19K to 31.83K
02-Mar-23 4:38 PM
View: 
Heggie Theresa
Director
BioCryst Pharmaceuticals Inc. (BCRX) 28-Feb-23Grant 635$8.85$5,619.752%
31.05K to 31.69K
02-Mar-23 4:41 PM
View: 
Ingram Robert Alexander
Director
BioCryst Pharmaceuticals Inc. (BCRX) 28-Feb-23Grant 2,259$8.85$19,992.202%
97.94K to 100.2K
02-Feb-23 5:20 PM
View: 
Stonehouse Jon P
President & CEO
Director
BioCryst Pharmaceuticals Inc. (BCRX) 01-Feb-23Option Exercise 100,000$5.45$545,000.0010%
1.03M to 1.13M
02-Feb-23 5:20 PM
View: 
Stonehouse Jon P
President & CEO
Director
BioCryst Pharmaceuticals Inc. (BCRX) 01-Feb-23Planned Option Sale 100,000$10.38$1,038,000.00(9%)
1.13M to 1.03M
02-Feb-23 5:15 PM
View: 
Lee Kenneth B Jr
Director
BioCryst Pharmaceuticals Inc. (BCRX) 31-Jan-23Option Exercise 15,000$1.71$25,650.0040%
37.12K to 52.12K
02-Feb-23 5:20 PM
View: 
Stonehouse Jon P
President & CEO
Director
BioCryst Pharmaceuticals Inc. (BCRX) 29-Dec-22Gift 10,000----< 1%
1.03M to 1.04M
02-Feb-23 5:20 PM
View: 
Stonehouse Jon P
President & CEO
Director
BioCryst Pharmaceuticals Inc. (BCRX) 29-Dec-22Gift 10,000----(< 1%)
1.04M to 1.03M